Cordarone X 200 150mg/3ml Injection
PDF Leaflet Revision Date: 12 April 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Control of tachydysrhythmias and cardiopulmonary resuscitation in resistant ventricular fibrillation.
Dosage (summary)
5 mg/kg IV infusion over 20 mins to 2 hours; max 1200 mg/24 hours.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Digoxin
- Warfarin
- Sofosbuvir
Contraindications
- Hypersensitivity to iodine
- Severe bradycardia
- Severe respiratory failure
- Thyroid dysfunction
Common side effects
- Bradycardia
- Hypotension
- Thyroid dysfunction
Counselling Points
- Monitor for bradycardia
- Avoid in pregnancy
- Use caution with driving
Serious warnings
- Pulmonary toxicity
- Severe bradycardia
- Risk of Torsade de Pointes
Important Disclaimer
The Cordarone X 200 150mg/3ml Injection professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
